Walker M, Black E J, Oehler V, Gillespie D A, Scott M T
Beatson Institute for Cancer Research, Garscube Estate, Glasgow, UK.
Oncogene. 2009 Jun 18;28(24):2314-23. doi: 10.1038/onc.2009.102. Epub 2009 May 4.
Chk1 is phosphorylated within its C-terminal regulatory domain by the upstream ATM/ATR kinases during checkpoint activation; however, how this modulates Chk1 function is poorly understood. Here, we show that Chk1 kinase activity is rapidly stimulated in a cell-cycle phase-specific manner in response to both DNA damage and replication arrest, and that the extent and duration of activation correlates closely with regulatory phosphorylation at serines (S) S317, S345 and S366. Despite their evident co-regulation, substitutions of individual Chk1 regulatory sites with alanine (A) residues have differential effects on checkpoint proficiency and kinase activation. Thus, whereas Chk1 S345 is essential for all functions tested, mutants lacking S317 or S366 retain partial proficiency for G2/M and S/M checkpoint arrests triggered by DNA damage or replication arrest. These phenotypes reflect defects in Chk1 kinase induction, as the mutants are either partially (317A and 366A) or completely (345A) resistant to kinase activation. Importantly, S345 phosphorylation is impaired in Chk1 S317A and S366A mutants, suggesting that modification of adjacent SQ sites promotes this key regulatory event. Finally, we provide biochemical evidence that Chk1 catalytic activity is stimulated by a de-repression mechanism.
在检查点激活过程中,Chk1在其C末端调节域内被上游的ATM/ATR激酶磷酸化;然而,目前对这种磷酸化如何调节Chk1功能的了解还很少。在此,我们表明,响应DNA损伤和复制停滞,Chk1激酶活性以细胞周期阶段特异性方式被快速激活,并且激活的程度和持续时间与丝氨酸(S)S317、S345和S366处的调节性磷酸化密切相关。尽管它们明显存在共同调节,但将Chk1单个调节位点替换为丙氨酸(A)残基对检查点功能和激酶激活有不同影响。因此,虽然Chk1 S345对所有测试功能都至关重要,但缺乏S317或S366的突变体在由DNA损伤或复制停滞触发的G2/M和S/M检查点停滞方面仍保留部分功能。这些表型反映了Chk1激酶诱导方面的缺陷,因为这些突变体对激酶激活要么部分(317A和366A)要么完全(345A)具有抗性。重要的是,Chk1 S317A和S366A突变体中S345的磷酸化受损,这表明相邻SQ位点的修饰促进了这一关键调节事件。最后,我们提供了生化证据表明Chk1催化活性是通过一种去抑制机制被刺激的。